D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Wave Life Sciences
WVE
$1.13B
| $5.4M | ﹤0.01% |
1,101,650
-153,910
| -12% | -$933K |
|
1902
PUT
AngloGold Ashanti
AU
$39.9B
| $5.4M | ﹤0.01% |
337,500
+235,000
| +229% | +$4.07M |
|
1903
PUT
Expeditors International
EXPD
$22.4B
| $5.4M | ﹤0.01% |
+45,300
| New | +$5.67M |
|
1904
CALL
West Pharmaceutical
WST
$23.7B
| $5.39M | ﹤0.01% |
+12,700
| New | +$5.35M |
|
|
VISN
1905
Vistance Networks Inc
VISN
$2.67B
| $5.39M | ﹤0.01% |
396,523
+382,684
| +2,765% | +$6.58M |
|
|
FRGE
1906
DELISTED
Forge Global Holdings
FRGE
| $5.36M | ﹤0.01% |
36,117
+12,799
| +55% | +$1.88M |
|
|
MBTC
1907
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
| $5.36M | ﹤0.01% |
+536,638
| New | +$5.32M |
|
1908
CALL
Prudential Financial
PRU
$43B
| $5.36M | ﹤0.01% |
50,900
-34,700
| -41% | -$3.58M |
|
1909
CALL
Constellation Brands
STZ
$22.5B
| $5.35M | ﹤0.01% |
25,400
+5,400
| +27% | +$1.18M |
|
1910
PUT
AstraZeneca
AZN
$267B
| $5.35M | ﹤0.01% |
44,520
| – | – |
|
1911
PUT
Equity Residential
EQR
$25.5B
| $5.33M | ﹤0.01% |
+65,900
| New | +$5.44M |
|
1912
PUT
Penumbra
PEN
$12.6B
| $5.33M | ﹤0.01% |
20,000
| – | – |
|
1913
Masco
MAS
$16.5B
| $5.32M | ﹤0.01% |
95,772
-239,750
| -71% | -$14.2M |
|
|
ZEN
1914
DELISTED
ZENDESK INC
ZEN
| $5.31M | ﹤0.01% |
45,639
-17,032
| -27% | -$2.2M |
|
1915
Anterix
ATEX
$1.78B
| $5.31M | ﹤0.01% |
87,435
+699
| +0.8% | +$41K |
|
1916
CALL
Monolithic Power Systems
MPWR
$63B
| $5.28M | ﹤0.01% |
+10,900
| New | +$4.96M |
|
1917
Kennametal
KMT
$2.71B
| $5.28M | ﹤0.01% |
154,272
+66,785
| +76% | +$2.4M |
|
|
CFIV
1918
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $5.28M | ﹤0.01% |
542,740
+260,097
| +92% | +$2.53M |
|
1919
Glacier Bancorp
GBCI
$6.45B
| $5.27M | ﹤0.01% |
95,177
+76,713
| +415% | +$4.04M |
|
1920
CALL
3M
MMM
$94.1B
| $5.26M | ﹤0.01% |
35,880
-50,830
| -59% | -$8.24M |
|
1921
Kimco Realty
KIM
$17.7B
| $5.25M | ﹤0.01% |
253,004
-2,058,280
| -89% | -$44M |
|
1922
Immersion
IMMR
$254M
| $5.25M | ﹤0.01% |
766,947
+386,881
| +102% | +$2.89M |
|
1923
Upbound Group
UPBD
$1.26B
| $5.24M | ﹤0.01% |
93,167
-120,873
| -56% | -$7.12M |
|
|
DHBC
1924
DELISTED
DHB Capital Corp. Class A common stock
DHBC
| $5.21M | ﹤0.01% |
537,286
+403,953
| +303% | +$3.91M |
|
|
AMWD
1925
DELISTED
American Woodmark
AMWD
| $5.21M | ﹤0.01% |
79,699
+18,046
| +29% | +$1.33M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.